SUREADHERE
For Public Health
A TB diagnosis doesn’t have to put your patient’s life on hold.
Support and engage patients throughout complex treatment regimens with SureAdhere.

Patient-Centered Support Tools for Better Public Health Outcomes
Tuberculosis (TB) continues to be one of the most challenging infectious diseases affecting over 10 million lives each year globally. SureAdhere revolutionizes TB care by making the gold standard of treatment – Directly Observed Therapy (DOT) – accessible and affordable for all. Our CDC-validated platform delivers equivalent treatment outcomes to in-person DOT while reducing the burden on patients and providers
Effectively support patients through TB, ensure compliance, and make the most of precious public health resources with SureAdhere.

Support Complex Regimens
Comprehensive treatment records, real-time communication, and virtual support tools like SMS and live virtual visits ensure patients receive the care they need, when they need it.
Scale Program Capacity
Maximize your impact by reaching more patients, observing more doses and saving administration costs. Reduce reliance on paper records and free up staff time for high-need patients.
Enable Offline Treatment Access
Ensure treatment continuity for all patients, regardless of their location or connectivity. SureAdhere’s user-friendly app supports patients with diverse backgrounds, needs and technical abilities.
Globally Trusted
Trusted by over 350 public health programs across the US, Europe and Asia, SureAdhere complies with stringent data privacy regulations like HIPAA and GDPR, and offers dedicated global support with service level agreements based on local time zones.

Proven Effective for TB Treatment
SureAdhere’s effectiveness in TB treatment is supported by rigorous scientific evidence.
A landmark CDC-led study, published in JAMA Network Open, demonstrated that SureAdhere’s video directly observed therapy (VDOT) is as effective as in-person DOT. These findings have shaped global TB treatment guidelines, including recommendations from the WHO and CDC. The updated CDC guidelines have allowed US health departments to widely adopt VDOT as the standard of care for TB treatment in their programs.

Additional Publich Health Use Cases

HIV Treatment & Prevention
SureAdhere supports both people living with HIV and those using PrEP to prevent HIV by making treatment and prevention simpler and more accessible. Its self-administered dose capture and virtual support help patients stay consistent, especially during the critical early stages of their routine.
With video directly-observed therapy and real-time data tracking, SureAdhere empowers patients to take control of their health while enabling providers to monitor progress and optimize care—eliminating the need for costly and time-consuming in-person visits.

Hepatitis C
SureAdhere streamlines Hepatitis C treatment by supporting patients in maintaining daily medication routines, crucial for preventing delayed recovery and drug resistance.
With treatment durations now as short as three months and a 95% success rate, SureAdhere’s platform ensures patients stay on track while empowering healthcare providers to monitor adherence effortlessly—leading to optimal outcomes and better health.
OUR PARTNERS





Publications and Research

Recommendations for Use of Video Directly Observed Therapy During Tuberculosis Treatment — United States, 2023

Feasibility and acceptability of asynchronous VOT among patients with MDR-TB

In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial